2020-12-04,Foghorn Therapeutics Announces Third Quarter 2020 Financial Results and Provides Corporate Update
2020-11-12,Foghorn Therapeutics Appoints Michael LaCascia as Chief Legal Officer
2020-10-23,"Foghorn Therapeutics, the Latest Biotech to Go Public, Rises 13% in Its Market Debut"
2020-10-22,Foghorn Therapeutics Announces Pricing of Initial Public Offering
